| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| ADH1C |
P00326
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
Enzyme
|
|
0.547 |
0.731 |
| CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| MMP12 |
P39900
|
matrix metallopeptidase 12
|
Enzyme
|
|
0.484 |
0.885 |
| COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| SRY |
Q05066
|
sex determining region Y
|
Transcription factor
|
|
0.456 |
0.808 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| GHS |
|
Goldenhar syndrome
|
|
|
0.659 |
0.615 |
| KCNQ1OT1 |
|
KCNQ1 opposite strand/antisense transcript 1
|
|
|
0.534 |
0.731 |
| POM121L9P |
|
POM121 transmembrane nucleoporin like 9, pseudogene
|
|
|
0.931 |
0.077 |
| TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| PTPRVP |
|
protein tyrosine phosphatase receptor type V, pseudogene
|
|
|
0.705 |
0.577 |
| SPAAR |
A0A1B0GVQ0
|
small regulatory polypeptide of amino acid response
|
|
|
0.711 |
0.385 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| MIRLET7I |
|
microRNA let-7i
|
|
|
0.575 |
0.615 |
| MIR122 |
|
microRNA 122
|
|
|
0.468 |
0.808 |
| MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |